T1	Outcomes 37 45	efficacy
T2	Outcomes 50 56	safety
T3	Outcomes 429 439	compliance
T4	Outcomes 635 650	non-inferiority
T5	Outcomes 670 707	safety of artesunate plus amodiaquine
T6	Outcomes 1240 1277	adequate response to treatment on D14
T7	Outcomes 1457 1463	safety
T8	Outcomes 1481 1509	incidence of adverse events.
T9	Outcomes 1640 1671	adequate responses to treatment
T10	Outcomes 1857 1872	non-inferiority
T11	Outcomes 1942 1957	well tolerated.
T12	Outcomes 1987 2013	gastrointestinal disorders
T13	Outcomes 2025 2033	pruritus
T14	Outcomes 2042 2057	safety profiles
T15	Outcomes 2131 2139	efficacy
T16	Outcomes 2144 2161	good tolerability
